News

THG provides global payer research, strategic planning and global value dossiers for biopharmaceutical products. THG, together with UBC’s existing value strategy and research services, will be led by

A large pharma firm can have tens or hundreds of thousands of employees in offices all around the globe; furthermore, there is the sheer variety of different departments

Dasatinib, an oral BCR-ABL inhibitor, was initially approved in November 2006 by the European Commission for the treatment of adults for all phases of CML (chronic, accelerated, or

Results from a randomised, Phase II study involving 111 patients showed the proportion of metastatic breast cancer patients without tumor progression at six months was 61.1% for those

The PEARL 3 study was part of an extensive worldwide clinical development program involving more than 2,900 subjects, which evaluated the safety and efficacy of Latuda. In this

Under the terms of this agreement, Bayer will provide clinical samples, sourced from clinical studies, and Prometheus will perform mutational analyses that characterise the presence or absence of

CRi develops and markets optical imaging systems to advance biomedical research and molecular-based drug and diagnostic development. CRi’s patented preclinical and tissue-based multiplexed analysis systems will expand Caliper‘s

Lotus‘ operating entity, Beijing Liang Fang Pharmaceutical, purchased the land-use rights for the property in 2008. Lotus had originally intended to build a pharmaceutical manufacturing and storage facility

Ness will succeed Allen Allen, the current chairman, president and CEO. During the past 25 years Ness has held various C level positions in both domestic, public, private